Detailed Information

Cited 0 time in webofscience Cited 0 time in scopus
Metadata Downloads

Current status of treatment for esophagojejunostomy leakage after total gastrectomy in patients with gastric cancer: a multicenter retrospective study in Koreaopen access

Authors
Kim, Min-ChanJung, Mi RanNoh, Jeong JuKang, SunghwaChung, Jae HunPark, Ji-HoKim, Tae-HanPark, Jae KyunKim, YoonhongSeo, Sang HyukKim, Sung EunKwon, Oh KyungPark, Ji YeonPark, Ki BumHwang, Sun-HwiLee, Si-HakLee, Young-JoonJeong, Sang-HoJeon, Tae-YongKim, Dae HwanChoi, Chang InYoon, Ki YoungSeo, Kyung WonKim, Ki HyunOh, Sang HoonKim, Kwang Hee
Issue Date
Dec-2025
Publisher
대한내시경복강경외과학회
Keywords
Anastomotic leak; Gastrectomy; Gastrointestinal endoscopy; Stomach neoplasms; Treatment outcome
Citation
Journal of Minimally Invasive Surgery, v.28, no.4, pp 184 - 192
Pages
9
Indexed
SCOPUS
KCI
Journal Title
Journal of Minimally Invasive Surgery
Volume
28
Number
4
Start Page
184
End Page
192
URI
https://scholarworks.gnu.ac.kr/handle/sw.gnu/81565
DOI
10.7602/jmis.2025.28.4.184
ISSN
2234-778X
2234-5248
Abstract
Purpose: Esophagojejunostomy leakage (EJL) remains one of the most critical complications following total gastrectomy for gastric cancer. This study aimed to evaluate the evolving therapeutic approaches and clinical outcomes of EJL using data from a large-scale multicenter retrospective cohort. Methods: Among 6,577 patients who underwent total gastrectomy or proximal gastrectomy with double tract reconstruction at nine institutions from 2003 to 2024, 196 (3.0%) developed EJL. Of these, 162 patients with comprehensive clinical data were included in the final analysis. The study examined treatment modalities, changes in management over time, patient characteristics, surgical variables, and clinical outcomes. Four groups were defined according to treatment approach: conservative, endoscopic, reoperation, and multimodal (combined) therapy. Results: Endoscopic therapy was first introduced in 2011 and has progressively supplanted reoperation, now comprising 32.5% of cases. The average time to EJL diagnosis was 8.4 days after surgery. Overall in-hospital mortality was 6.1% (10/162). When conservative management was excluded, endoscopic treatment demonstrated the highest rate of therapeutic success (94.3%, p = 0.004). Both the duration until diet resumption and length of hospital stay were notably reduced in the endoscopic and conservative groups compared with reoperation and multimodal therapy (p < 0.001). Moreover, although the highest post-leakage hospitalization costs were observed with multimodal treatment (p < 0.001), overall hospitalization expenses were significantly lower for patients managed conservatively or with endoscopic intervention (p < 0.001). Conclusion: Over the past two decades, management of EJL has shifted toward endoscopic approaches. Endoscopic therapies yield superior clinical outcomes and should be considered a primary option for appropriate candidates.
Files in This Item
There are no files associated with this item.
Appears in
Collections
College of Medicine > Department of Medicine > Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher PARK, Ji Ho photo

PARK, Ji Ho
의과대학 (의학과)
Read more

Altmetrics

Total Views & Downloads

BROWSE